Company News

OTC: CLCS

Stock Information

SHARE PRICE: $0.818

VOLUME: 3,900

MARKET CAP: $55,552,532.00

SHARE COUNT: 67,945,856

DAILY HIGH: $0.85

DAILY LOW: $0.85

OPEN: $0.85

CLOSE: $0.818

PREV. CLOSE: $0.818

CHANGE: $0.00000000000000 (0%)

52-WEEK HIGH: $2.25

52-WEEK LOW: $0.182

LAST UPDATED: 19 hours ago

NEW YORK CITY, NEW YORK / ACCESS Newswire / January 15, 2026 /Cell Source, Inc. (OTC Pink Limited:CLCS) ("Cell Source" or the "Company"), a leading innovator in immune tolerance management, announced today that it has closed a private placement of ...

Brought to you by Yahoo! Finance
15 Jan, 2026 / 21:01

Investor Relations Contact

Cell Source, Inc.
57 West 57th Street, Suite 400
New York, NY 10019

+1 646 416-7896 Phone
+1 646 416-8001 Fax
Email: info@cell-source.com

Securities Counsel

Giordano Halleran & Ciesla
Philip D. Forlenza, Esq.
125 Half Mile Road, Suite 300
Red Bank, NJ 07701-6777

Phone: 732-741-3900
Email: PForlenza@ghclaw.com
WWW: www.ghclaw.com

Independent Auditor

Marcum LLP
750 Third Ave, 11th Floor
New York, NY 10017

Additional Information

Subscribe to Cell Source’s Newsletter

    INVESTOR ALERTS. PRESS RELEASES. INDUSTRY & COMPANY NEWS.

    Get the latest Cell Source news and updates, delivered right to your inbox.